Hogarty G E, Anderson C M, Reiss D J, Kornblith S J, Greenwald D P, Javna C D, Madonia M J
Arch Gen Psychiatry. 1986 Jul;43(7):633-42. doi: 10.1001/archpsyc.1986.01800070019003.
Relapse rates averaging 41% in the first year after discharge among schizophrenic patients receiving maintenance neuroleptic treatment led to the development of two disorder-relevant treatments: a patient-centered behavioral treatment and a psychoeducational family treatment. Following hospital admission, 103 patients residing in high expressed emotion (EE) households who met Research Diagnostic Criteria for schizophrenia or schizoaffective disorder were randomly assigned to a two-year aftercare study of family treatment and medication, social skills training and medication, their combination, or a drug-treated condition. First-year relapse rates among those exposed to treatment demonstrate a main effect for family treatment (19%), a main effect for social skills training (20%), and an additive effect for the combined conditions (0%) relative to controls (41%). Effects are explained, in part, by the absence of relapse in any household that changed from high to low EE. Only the combination of treatment sustains a remission in households that remain high in EE. Continuing study, however, suggests a delay of relapse rather than prevention.
接受维持性抗精神病药物治疗的精神分裂症患者出院后第一年的平均复发率为41%,这促使了两种与疾病相关的治疗方法的发展:以患者为中心的行为治疗和心理教育家庭治疗。在入院后,103名居住在高情感表达(EE)家庭中、符合精神分裂症或分裂情感性障碍研究诊断标准的患者被随机分配到一项为期两年的后续护理研究中,分别接受家庭治疗与药物治疗、社交技能训练与药物治疗、两者结合治疗或单纯药物治疗。与对照组(41%)相比,接受治疗的患者第一年复发率显示出家庭治疗的主要效果(19%)、社交技能训练的主要效果(20%)以及联合治疗的叠加效果(0%)。部分效果可通过从高EE转变为低EE的家庭中无复发情况来解释。只有联合治疗能使EE水平持续较高的家庭维持缓解状态。然而,持续的研究表明这是复发延迟而非预防。